Table of Content

1 Oral Sustained and Controlled Release Formulations Market Overview
1.1 Product Overview and Scope of Oral Sustained and Controlled Release Formulations
1.2 Oral Sustained and Controlled Release Formulations Segment by Type
1.2.1 Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034)
1.2.2 Skeleton Type
1.2.3 Membrane Controlled Type
1.2.4 Osmotic Pump Type
1.3 Oral Sustained and Controlled Release Formulations Segment by Application
1.3.1 Global Oral Sustained and Controlled Release Formulations Market Value by Application: (2024-2034)
1.3.2 Cardiovascular System Drugs
1.3.3 Nervous System Drugs
1.3.4 Digestive System and Metabolism
1.3.5 Other
1.4 Global Oral Sustained and Controlled Release Formulations Market Size Estimates and Forecasts
1.4.1 Global Oral Sustained and Controlled Release Formulations Revenue 2018-2029
1.4.2 Global Oral Sustained and Controlled Release Formulations Sales 2018-2029
1.4.3 Global Oral Sustained and Controlled Release Formulations Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Sustained and Controlled Release Formulations Market Competition by Manufacturers
2.1 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2018-2024)
2.2 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Oral Sustained and Controlled Release Formulations Average Price by Manufacturers (2018-2024)
2.4 Global Oral Sustained and Controlled Release Formulations Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Product Type & Application
2.7 Oral Sustained and Controlled Release Formulations Market Competitive Situation and Trends
2.7.1 Oral Sustained and Controlled Release Formulations Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Sustained and Controlled Release Formulations Players Market Share by Revenue
2.7.3 Global Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Sustained and Controlled Release Formulations Retrospective Market Scenario by Region
3.1 Global Oral Sustained and Controlled Release Formulations Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Sustained and Controlled Release Formulations Global Oral Sustained and Controlled Release Formulations Sales by Region: 2018-2029
3.2.1 Global Oral Sustained and Controlled Release Formulations Sales by Region: 2018-2024
3.2.2 Global Oral Sustained and Controlled Release Formulations Sales by Region: 2024-2029
3.3 Global Oral Sustained and Controlled Release Formulations Global Oral Sustained and Controlled Release Formulations Revenue by Region: 2018-2029
3.3.1 Global Oral Sustained and Controlled Release Formulations Revenue by Region: 2018-2024
3.3.2 Global Oral Sustained and Controlled Release Formulations Revenue by Region: 2024-2029
3.4 North America Oral Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.4.1 North America Oral Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.4.3 North America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.5.1 Europe Oral Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.5.3 Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.7.1 Latin America Oral Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.7.3 Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029)
4.1.1 Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024)
4.1.2 Global Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029)
4.1.3 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
4.2 Global Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
4.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024)
4.2.2 Global Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029)
4.2.3 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
4.3 Global Oral Sustained and Controlled Release Formulations Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
5.1.1 Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024)
5.1.2 Global Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029)
5.1.3 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
5.2 Global Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
5.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024)
5.2.2 Global Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029)
5.2.3 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
5.3 Global Oral Sustained and Controlled Release Formulations Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Humanwell Healthcare Co.,Ltd.
6.1.1 Humanwell Healthcare Co.,Ltd. Corporation Information
6.1.2 Humanwell Healthcare Co.,Ltd. Description and Business Overview
6.1.3 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.1.5 Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
6.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
6.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.4 Qilu Pharmaceutical Co Ltd
6.4.1 Qilu Pharmaceutical Co Ltd Corporation Information
6.4.2 Qilu Pharmaceutical Co Ltd Description and Business Overview
6.4.3 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Portfolio
6.4.5 Qilu Pharmaceutical Co Ltd Recent Developments/Updates
6.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
6.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Corporation Information
6.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
6.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
6.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.7 PKU HealthCare Corp.,Ltd.
6.6.1 PKU HealthCare Corp.,Ltd. Corporation Information
6.6.2 PKU HealthCare Corp.,Ltd. Description and Business Overview
6.6.3 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.4.4 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.7.5 PKU HealthCare Corp.,Ltd. Recent Developments/Updates
6.8 Overseas Pharmaceuticals, Ltd.
6.8.1 Overseas Pharmaceuticals, Ltd. Corporation Information
6.8.2 Overseas Pharmaceuticals, Ltd. Description and Business Overview
6.8.3 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Portfolio
6.8.5 Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
6.9 Novast Laboratories (China), LTD.
6.9.1 Novast Laboratories (China), LTD. Corporation Information
6.9.2 Novast Laboratories (China), LTD. Description and Business Overview
6.9.3 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Portfolio
6.9.5 Novast Laboratories (China), LTD. Recent Developments/Updates
6.10 Catalent
6.10.1 Catalent Corporation Information
6.10.2 Catalent Description and Business Overview
6.10.3 Catalent Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Catalent Oral Sustained and Controlled Release Formulations Product Portfolio
6.10.5 Catalent Recent Developments/Updates
6.11 AstraZeneca Plc
6.11.1 AstraZeneca Plc Corporation Information
6.11.2 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Description and Business Overview
6.11.3 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.11.4 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Portfolio
6.11.5 AstraZeneca Plc Recent Developments/Updates
6.12 Oakwood Labs
6.12.1 Oakwood Labs Corporation Information
6.12.2 Oakwood Labs Oral Sustained and Controlled Release Formulations Description and Business Overview
6.12.3 Oakwood Labs Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Oakwood Labs Oral Sustained and Controlled Release Formulations Product Portfolio
6.12.5 Oakwood Labs Recent Developments/Updates
6.13 Ascendia Pharma
6.13.1 Ascendia Pharma Corporation Information
6.13.2 Ascendia Pharma Oral Sustained and Controlled Release Formulations Description and Business Overview
6.13.3 Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Portfolio
6.13.5 Ascendia Pharma Recent Developments/Updates
6.14 Colorcon
6.14.1 Colorcon Corporation Information
6.14.2 Colorcon Oral Sustained and Controlled Release Formulations Description and Business Overview
6.14.3 Colorcon Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Colorcon Oral Sustained and Controlled Release Formulations Product Portfolio
6.14.5 Colorcon Recent Developments/Updates
6.15 Pfizer Inc.
6.15.1 Pfizer Inc. Corporation Information
6.15.2 Pfizer Inc. Oral Sustained and Controlled Release Formulations Description and Business Overview
6.15.3 Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Portfolio
6.15.5 Pfizer Inc. Recent Developments/Updates
6.16 Mylan
6.16.1 Mylan Corporation Information
6.16.2 Mylan Oral Sustained and Controlled Release Formulations Description and Business Overview
6.16.3 Mylan Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Mylan Oral Sustained and Controlled Release Formulations Product Portfolio
6.16.5 Mylan Recent Developments/Updates
6.17 Sandoz
6.17.1 Sandoz Corporation Information
6.17.2 Sandoz Oral Sustained and Controlled Release Formulations Description and Business Overview
6.17.3 Sandoz Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Sandoz Oral Sustained and Controlled Release Formulations Product Portfolio
6.17.5 Sandoz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Sustained and Controlled Release Formulations Industry Chain Analysis
7.2 Oral Sustained and Controlled Release Formulations Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Sustained and Controlled Release Formulations Production Mode & Process
7.4 Oral Sustained and Controlled Release Formulations Sales and Marketing
7.4.1 Oral Sustained and Controlled Release Formulations Sales Channels
7.4.2 Oral Sustained and Controlled Release Formulations Distributors
7.5 Oral Sustained and Controlled Release Formulations Customers
8 Oral Sustained and Controlled Release Formulations Market Dynamics
8.1 Oral Sustained and Controlled Release Formulations Industry Trends
8.2 Oral Sustained and Controlled Release Formulations Market Drivers
8.3 Oral Sustained and Controlled Release Formulations Market Challenges
8.4 Oral Sustained and Controlled Release Formulations Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oral Sustained and Controlled Release Formulations Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oral Sustained and Controlled Release Formulations Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Oral Sustained and Controlled Release Formulations Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Oral Sustained and Controlled Release Formulations Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Oral Sustained and Controlled Release Formulations, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Product Type & Application
Table 12. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Sustained and Controlled Release Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Sustained and Controlled Release Formulations as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 18. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2024)
Table 19. Global Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 20. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2024-2029)
Table 21. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2024)
Table 23. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2024-2029)
Table 25. North America Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 27. North America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 28. North America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 32. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 33. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 51. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2024-2029)
Table 52. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2024)
Table 53. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2024-2029)
Table 54. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2024)
Table 57. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2024-2029)
Table 58. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2018-2024)
Table 59. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2024-2029)
Table 60. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Application (2018-2024)
Table 61. Global Oral Sustained and Controlled Release Formulations Sales (K Units) by Application (2024-2029)
Table 62. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2024)
Table 63. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2024-2029)
Table 64. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Oral Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2024)
Table 67. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2024-2029)
Table 68. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2018-2024)
Table 69. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2024-2029)
Table 70. Humanwell Healthcare Co.,Ltd. Corporation Information
Table 71. Humanwell Healthcare Co.,Ltd. Description and Business Overview
Table 72. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 74. Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
Table 75. Nanjing Yiheng Pharmaceutical Co., Ltd. Corporation Information
Table 76. Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 79. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Qilu Pharmaceutical Co Ltd Corporation Information
Table 86. Qilu Pharmaceutical Co Ltd Description and Business Overview
Table 87. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product
Table 89. Qilu Pharmaceutical Co Ltd Recent Developments/Updates
Table 90. Shanghai Pharmaceuticals Holding Co.,Ltd. Corporation Information
Table 91. Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
Table 92. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 94. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 97. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 100. PKU HealthCare Corp.,Ltd. Corporation Information
Table 101. PKU HealthCare Corp.,Ltd. Description and Business Overview
Table 102. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 104. PKU HealthCare Corp.,Ltd. Recent Developments/Updates
Table 105. Overseas Pharmaceuticals, Ltd. Corporation Information
Table 106. Overseas Pharmaceuticals, Ltd. Description and Business Overview
Table 107. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product
Table 109. Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
Table 110. Novast Laboratories (China), LTD. Corporation Information
Table 111. Novast Laboratories (China), LTD. Description and Business Overview
Table 112. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product
Table 114. Novast Laboratories (China), LTD. Recent Developments/Updates
Table 115. Catalent Corporation Information
Table 116. Catalent Description and Business Overview
Table 117. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Catalent Oral Sustained and Controlled Release Formulations Product
Table 119. Catalent Recent Developments/Updates
Table 120. AstraZeneca Plc Corporation Information
Table 121. AstraZeneca Plc Description and Business Overview
Table 122. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product
Table 124. AstraZeneca Plc Recent Developments/Updates
Table 125. Oakwood Labs Corporation Information
Table 126. Oakwood Labs Description and Business Overview
Table 127. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Oakwood Labs Oral Sustained and Controlled Release Formulations Product
Table 129. Oakwood Labs Recent Developments/Updates
Table 130. Ascendia Pharma Corporation Information
Table 131. Ascendia Pharma Description and Business Overview
Table 132. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product
Table 134. Ascendia Pharma Recent Developments/Updates
Table 135. Colorcon Corporation Information
Table 136. Colorcon Description and Business Overview
Table 137. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Colorcon Oral Sustained and Controlled Release Formulations Product
Table 139. Colorcon Recent Developments/Updates
Table 140. Pfizer Inc. Corporation Information
Table 141. Pfizer Inc. Description and Business Overview
Table 142. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product
Table 144. Pfizer Inc. Recent Developments/Updates
Table 145. Mylan Corporation Information
Table 146. Mylan Description and Business Overview
Table 147. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Mylan Oral Sustained and Controlled Release Formulations Product
Table 149. Mylan Recent Developments/Updates
Table 150. Sandoz Corporation Information
Table 151. Sandoz Description and Business Overview
Table 152. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Sandoz Oral Sustained and Controlled Release Formulations Product
Table 154. Sandoz Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Oral Sustained and Controlled Release Formulations Distributors List
Table 158. Oral Sustained and Controlled Release Formulations Customers List
Table 159. Oral Sustained and Controlled Release Formulations Market Trends
Table 160. Oral Sustained and Controlled Release Formulations Market Drivers
Table 161. Oral Sustained and Controlled Release Formulations Market Challenges
Table 162. Oral Sustained and Controlled Release Formulations Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Sustained and Controlled Release Formulations
Figure 2. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oral Sustained and Controlled Release Formulations Market Share by Type in 2022 & 2029
Figure 4. Skeleton Type Product Picture
Figure 5. Membrane Controlled Type Product Picture
Figure 6. Osmotic Pump Type Product Picture
Figure 7. Global Oral Sustained and Controlled Release Formulations Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Oral Sustained and Controlled Release Formulations Market Share by Application in 2022 & 2029
Figure 9. Cardiovascular System Drugs
Figure 10. Nervous System Drugs
Figure 11. Digestive System and Metabolism
Figure 12. Other
Figure 13. Global Oral Sustained and Controlled Release Formulations Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Oral Sustained and Controlled Release Formulations Market Size (2018-2029) & (US$ Million)
Figure 15. Global Oral Sustained and Controlled Release Formulations Sales (2018-2029) & (K Units)
Figure 16. Global Oral Sustained and Controlled Release Formulations Average Price (US$/Unit) & (2018-2029)
Figure 17. Oral Sustained and Controlled Release Formulations Report Years Considered
Figure 18. Oral Sustained and Controlled Release Formulations Sales Share by Manufacturers in 2022
Figure 19. Global Oral Sustained and Controlled Release Formulations Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Oral Sustained and Controlled Release Formulations Players: Market Share by Revenue in 2022
Figure 21. Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Oral Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 24. North America Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 25. United States Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 28. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 29. Germany Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2029)
Figure 36. China Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 44. Latin America Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Oral Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Sustained and Controlled Release Formulations by Type (2018-2029)
Figure 54. Global Revenue Market Share of Oral Sustained and Controlled Release Formulations by Type (2018-2029)
Figure 55. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Oral Sustained and Controlled Release Formulations by Application (2018-2029)
Figure 57. Global Revenue Market Share of Oral Sustained and Controlled Release Formulations by Application (2018-2029)
Figure 58. Global Oral Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2018-2029)
Figure 59. Oral Sustained and Controlled Release Formulations Value Chain
Figure 60. Oral Sustained and Controlled Release Formulations Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed